Lincoln Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹678.55₹689.8552 Week's Low
52 Week's High
₹472₹811.85
| Returns % | |
| 1 Month Return | -13.46 % |
| 3 Month Return | + 4 % |
| 1 Year Return | + 36.06 % |
| Market Stats | |
| Previous Close | ₹686.00 |
| Open | ₹682.60 |
| Volume | 21.54K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,374.04Cr |
Lincoln Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 14.03 |
| PEG Ratio | 1.33 |
| Market Cap | ₹1,374.04 Cr |
| P/B Ratio | 1.98 |
| EPS | 46.58 |
| Dividend Yield | 0.31 |
| Sector | Pharmaceuticals |
| ROE | 17.04 |
Lincoln Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,374.04 Cr | 75.01% | 0.50 | ₹93 Cr | ₹580 Cr | |
| BUY | ₹13,935.81 Cr | 73.43% | 0.66 | -₹95 Cr | ₹4,051 Cr | |
| NA | ₹2,884.81 Cr | 3.71% | 0.58 | -₹154 Cr | ₹2,615 Cr | |
| NA | ₹46.86 Cr | 15.02% | 0.51 | ₹1 Cr | ₹62 Cr | |
| NA | ₹1,425.35 Cr | 223.33% | 0.53 | ₹50 Cr | ₹614 Cr |
About Lincoln Pharmaceuticals Ltd
Share Price: ₹683.00 per share as on 11 Oct, 2024 04:01 PM
Market Capitalisation: ₹1,374.04Cr as of today
Revenue: ₹147.28Cr as on June 2024 (Q2 24)
Net Profit: ₹23.67Cr as on June 2024 (Q2 24)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
| Organisation | Lincoln Pharmaceuticals Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Lincoln Pharmaceuticals Ltd
Lincoln Pharma Reports Strong Q1 FY25 Earnings - 09 Aug, 2024
Lincoln Pharmaceuticals reported a 24.51% increase in net profit to Rs 23.67 crore for Q1 FY25, with total income rising by 10% to Rs 157.69 crore. The company anticipates further growth and aims for Rs 750 crore in revenue by FY26.
Lincoln Pharma Reports Strong Q1 FY25 Earnings - 08 Aug, 2024
Lincoln Pharmaceuticals announced a 24.51% increase in net profit for Q1 FY25, reaching Rs 23.67 crore. Total income rose by 10% to Rs 157.69 crore, with robust growth in both domestic and export operations. The company aims for Rs 750 crore revenue in FY26, driven by growth strategies and market expansion.
Insights on Lincoln Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 3.93% to 3.95% in Jun 2024 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 18.6 Cr → 23.67 Cr (in ₹), with an average increase of 21.4% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 149.51 Cr → 157.69 Cr (in ₹), with an average increase of 5.2% per quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 49.53% to 49.78% in Jun 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 126.7% return, outperforming this stock by 49.9%
- NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 82.6% return, outperforming this stock by 46.6%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 46.49% to 46.24% in Jun 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, LINCOLN stock has moved down by -13.5%
Lincoln Pharmaceuticals Ltd Financials
Index Inclusions
Lincoln Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.78% | 0.49 | |
| Foreign Institutions | 3.95% | 0.46 | |
| Mutual Funds | 0% | 16.67 | |
| Retail Investors | 46.24% | ||
| Others | 0.04% |
Lincoln Pharmaceuticals Ltd Key Indicators
Lincoln Pharmaceuticals Ltd Valuation
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (14.03x)
October 10, 2024
Industry (58.96x)
October 10, 2024
Highest (18.47x)
January 23, 2018
Lincoln Pharmaceuticals Ltd Earnings and Dividends
Lincoln Pharmaceuticals Ltd Earnings Results
Lincoln Pharmaceuticals Ltd’s net profit jumped 24.51% since last year same period to ₹23.67Cr in the Q1 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 27.26% jump in its net profits since last 3-months.
Read More about Earnings ResultsLincoln Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.48%.
Read More about Dividends
Lincoln Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Lincoln Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Lincoln Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Lincoln Pharmaceuticals Ltd shares.
Lincoln Pharmaceuticals Ltd (LINCOLN) share price today is ₹683
Lincoln Pharmaceuticals Ltd is listed on NSE
Lincoln Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Lincoln Pharmaceuticals Ltd is ₹689.85.
- Today’s lowest price of Lincoln Pharmaceuticals Ltd is ₹678.55.
PE Ratio of Lincoln Pharmaceuticals Ltd is 14.03
PE ratio = Lincoln Pharmaceuticals Ltd Market price per share / Lincoln Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 21.54K.
Today’s market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1374.04Cr.
| Lincoln Pharmaceuticals Ltd(LINCOLN | Price |
|---|---|
52 Week High | ₹811.85 |
52 Week Low | ₹472 |
Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹683. It is down -15.87% from its 52 Week High price of ₹811.85
Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹683. It is up 44.70% from its 52 Week Low price of ₹472
| Lincoln Pharmaceuticals Ltd(LINCOLN | Returns |
|---|---|
1 Day Returns | -3% |
1 Month Returns | -13.46% |
3 Month Returns | 4% |
1 Year Returns | 36.06% |